Testing effectiveness (Phase 2)Ended earlyNCT02355184What this trial is testingAn Extension of Protocol PRO 140_CD01 StudyWho this might be right forHIVHuman Immunodeficiency Virus CytoDyn, Inc. 20
Not applicableLooking for participantsNCT01568697What this trial is testingOral Bacteria and Immune System Problems Involved in Gum Disease (Periodontitis)Who this might be right forImmunosuppressionPeriodontal DiseaseHealthy Subjects+1 more National Institute of Dental and Craniofacial Research (NIDCR) 700
Post-approval studies (Phase 4)Ended earlyNCT00148252What this trial is testingLowering Total Immunosuppressive Load in Renal Transplant Recipients More Than 12 Months PosttransplantWho this might be right forRenal Transplantation University of Oslo School of Pharmacy 298
Not applicableStudy completedNCT00234117What this trial is testingImprovement in Bronchial Asthma in Patients With Extraesophageal Reflux After Acid SuppressionWho this might be right forBronchial AsthmaGastroesophageal Reflux Ponce Gastroenterology Research 40
Post-approval studies (Phase 4)Study completedNCT01599364What this trial is testingAtazanavir/r + Lamivudine Dual TherapyWho this might be right forHuman Immunodeficiency Virus Catholic University of the Sacred Heart 266
Large-scale testing (Phase 3)Study completedNCT01707849What this trial is testingThe Impact of Everolimus Based Immunosuppression in the Evolution of Hepatitis C Fibrosis After Liver TransplantationWho this might be right forHepatitis C Recurrence After Liver Transplant Hospital Vall d'Hebron 18
Testing effectiveness (Phase 2)UnknownNCT00295425What this trial is testingCYA Versus MMF for Treatment of Moderate-Severe Psoriasis.Who this might be right forPsoriasis University Hospital Muenster 50
Not applicableStudy completedNCT00714480What this trial is testingThymoglobulin: Presence and Affect in the Central Lymphatic CompartmentWho this might be right forRenal TransplantationImmunosuppression Swedish Medical Center 3
Large-scale testing (Phase 3)Study completedNCT00067782What this trial is testingA Phase IIIB Study Evaluating the Effect on Serum Lipids Following a Switch to Atazanavir in HIV Infected Subjects Evidencing Virologic Suppression on Their First PI-Based Antiretroviral TherapyWho this might be right forHIV Infections Bristol-Myers Squibb
Post-approval studies (Phase 4)Study completedNCT00160966What this trial is testingImpact of Immunosuppressive Regimens on Polyomavirus-related Transplant NephropathyWho this might be right forPolyomavirus Infections University of Giessen 108
Not applicableLooking for participantsNCT06510894What this trial is testingDiagnostic Utility of SGLT1/2 Inhibition to Facilitate Myocardial Glucose SuppressionWho this might be right forCardiac Sarcoidosis University of Pennsylvania 40
Large-scale testing (Phase 3)UnknownNCT00929812What this trial is testingGlucagon Modulation of Ghrelin SecretionWho this might be right forHealthy SubjectsObesityDiabetes Mellitus, Type 1 Charite University, Berlin, Germany 38
Post-approval studies (Phase 4)Study completedNCT00931801What this trial is testingBATAR: Individuals Currently Taking Boosted Atazanavir as Part of an HIV Treatment Regimen Will be Evaluated to See if Substituting Raltegravir for Nucleoside Transcriptase Inhibitors Will be Safe and Well Tolerated.Who this might be right forHIV Community Research Initiative of New England 43
Not applicableLooking for participantsNCT06463119What this trial is testingRegistry of Vaccine Responses in Immune Compromised PatientsWho this might be right forImmunosuppression Laure Pittet, MD-PhD 300
Large-scale testing (Phase 3)Study completedNCT03403569What this trial is testingSafety and Efficacy of Triptolide Wilfordii in New Onset HIV-1 InfectionWho this might be right forHIV-infection/AIDS Peking Union Medical College Hospital 353
Not applicableStudy completedNCT04506528What this trial is testingCOVID EHR COHORT at the University of WisconsinWho this might be right forCOVID-19CancerNicotine Dependence+3 more University of Wisconsin, Madison 1,634,381
Testing effectiveness (Phase 2)Study completedNCT00342134What this trial is testingImmunological Mechanisms of Hematopoietic Stem Cell Transplantation in Multiple SclerosisWho this might be right forMultiple Sclerosis National Institute of Neurological Disorders and Stroke (NINDS) 34
Post-approval studies (Phase 4)Study completedNCT00637585What this trial is testingFexofenadine HCl 180 mg, Desloratadine 5 mg and Placebo in Suppression of Wheal and Flare Induced by HistamineWho this might be right forAllergic Rhinitis Sanofi 42
Not applicableStudy completedNCT04288271What this trial is testingTeen Adherence in KidnEy Transplant Improving Tracking To Optimize Outcomes - Stage 3Who this might be right forMedication AdherenceKidney Transplantation McGill University Health Centre/Research Institute of the McGill University Health Centre 96
Large-scale testing (Phase 3)Study completedNCT02040584What this trial is testingA Multicentre, Randomised, Open-label, Controlled, 12-month Follow-up Study to Assess Impact on Renal Function of an Immunosuppression Regimen Based on Tacrolimus Minimisation in Association With Everolimus in de Novo Liver Transplant Recipients.Who this might be right forLiver Transplant Novartis Pharmaceuticals 217